海外の治験の状況「1」での検索結果
2039件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- A study to investigate the effects of the course of first-line therapy with gemcitabine on the success of second-line therapy with NAL-IRI combination therapy
- locally advanced or metastatic pancreatic cancer after failure of a gemcitabine/nab-paclitaxel 1st-line treatment MedDRA version: 20.0 Level: LLT Classification code 10033604 Term: Pancreatic cancer System Organ Class: 100000004864 MedDRA version: 20.0 Level: LLT Classification code 10033605 Term: Pancreatic cancer metastatic System Organ Class: 100000004864 MedDRA version: 20.0 Level: LLT Classification code 10033606 Term: Pancreatic cancer non-resectable System Organ Class: 100000004864 MedDRA version: 20.0 Level: LLT Classification code 10033607 Term: Pancreatic cancer recurrent System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Germany
- 2017-10-09
Authorised
- Arginine as medication to improve outcome in patients with galactosemia
- Classic galactosemia;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Netherlands
- 2017-09-13
Authorised
- A multicenter randomized phase 2 study to compare the efficacy and safety of avelumab versus standard second line treatment, in patients with metastatic colorectal cancer (MMR) after first line treatment progression.
- COLORECTAL METASTATIC CANCER WITH MICROSATELLITE INSTABILITY (MSI);Therapeutic area: Diseases [C] - Cancer [C04]
- France
- 2017-07-12
Authorised
- FOLFIRI + panitumumab in second-line in subjects with wild type RAS metastatic colorectal cancer who have received FOLFOX + panitumumab in first-line
- Subjects treated in first-line with panitumumab and FOLFOX and having at least achieved stable disease with wild type RAS metastatic Colorectal Cancer confirmed in liquid biopsies before starting second line treatment will be screened for this trial. Only subjects who have interrupted panitumumab for MedDRA version: 20.0 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Spain
- 2018-04-09
Authorised
- ENSAYO PILOTO CON IMATINIB PARA PACIENTES CON NEUROFIBROMA PLEXIFORME ASOCIADO A LA NEUROFIBROMATOSIS TIPO I. PILOT STUDY WITH IMATINIB FOR PLEXIFORM NEUROFIBROMA IN NEUROFIBROMATOSIS TYPE I PATIENTS
- Tratamiento de los neurofibromas plexiformes de alto riesgo no abordables quirúrgicamente en pacientes con neurofibromatosis tipo I
- Spain
- 2009-11-19
Authorised
- [Targetspezifische Second-line-Therapie des metastasierten Urothelkarzinoms mit Temsirolimus] Target-specific therapy of metastatic urothelial carcinoma with temsirolimus - Targetspezifische Second-line-Therapie des metastasierten Urothelkarzinoms mit Temsirolimus
- Chemotherapy refractory metastatic urothelia carcinoma MedDRA version: 9.1 Level: LLT Classification code 10064467 Term: Urothelial carcinoma
- Germany
- 2009-01-20
Authorised
- AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE III STUDY OF SECOND-LINE CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN METASTATIC COLORECTAL CANCER PATIENTS WHO HAVE RECEIVED FIRST-LINE CHEMOTHERAPY PLUS BEVACIZUMAB - BEBYP
- METASTATIC COLORECTAL CANCER PATIENTS MedDRA version: 9.1 Level: LLT Classification code 10052358 Term: Colorectal cancer metastatic
- Italy
- 2008-02-06
Authorised
- Use of biological marker (ABCB1/P-glycoprotein) as factor able to distinguish patients having different risk of recurrence in osteosarcoma
- Non metastatic osteosarcoma of the extremities MedDRA version: 14.0 Level: PT Classification code 10031293 Term: Osteosarcoma localised System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Italy
- 2011-09-02
Authorised
- Comparison between beta-adrenergic blockers and angiotensin II receptor antagonists for the treatment of late hypertension in patients with repaired aortic coarctation - Treatment of late hypertension in aortic coarctation
- Aortic coarctation and late hypertension
- Netherlands
- 2006-12-22
Authorised
- A Study to Investigate Dance 501 (Human Insulin Inhalation Solution and Inhaler) in Subjects with Type 1 Diabetes Mellitus (T1DM)
- Type 1 Diabetes Mellitus br>MedDRA version: 20.0 Level: PT Classification code 10067584 Term: Type 1 diabetes mellitus System Organ Class: 10027433 - Metabolism and nutrition disorders ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Germany
- 2018-09-25